UTRACT Trademark

Trademark Overview

On Monday, December 11, 2023, a trademark application was filed for UTRACT with the United States Patent and Trademark Office. The USPTO has given the UTRACT trademark a serial number of 98307746. The federal status of this trademark filing is REGISTERED as of Tuesday, January 14, 2025. This trademark is owned by UroGen Pharma Ltd.. The UTRACT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
utract

General Information

Serial Number98307746
Word MarkUTRACT
Filing DateMonday, December 11, 2023
Status700 - REGISTERED
Status DateTuesday, January 14, 2025
Registration Number7648975
Registration DateTuesday, January 14, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 11, 2023
Primary Code042
First Use Anywhere DateFriday, September 30, 2022
First Use In Commerce DateFriday, September 30, 2022

Trademark Owner History

Party NameUroGen Pharma Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRa'anana 4365007
IL
Party NameUroGen Pharma Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRa'anana 4365007
IL
Party NameUroGen Pharma Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRa'anana 4365007
IL

Trademark Events

Event DateEvent Description
Monday, December 11, 2023NEW APPLICATION ENTERED
Monday, March 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 10, 2024ASSIGNED TO EXAMINER
Friday, July 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 30, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, September 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 4, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 14, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, March 10, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, August 31, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, August 31, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, August 31, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, August 31, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Sunday, August 31, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, August 31, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, August 31, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 10, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

utract pharmaceuticals clinical trials field information medical scientific research providing